Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1294
| Despition | DCC Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1445 | Human RAB4A Protein (AC1445) | 2 µg | inquiry |
| ACPP-1532 | Human CLTB Protein (AC1532) | 5 µg | inquiry |
| ACPP-1120 | Human NRG1 Protein (AC1120) | 10 µg | inquiry |
| ACPP-1147 | Recombinant Human NRP2 Protein (6×His Tag) (AC1147) | 50 µg | inquiry |
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
| ACPP-1524 | Human TARDBP (1-414) Protein (AC1524) | 5 µg | inquiry |
| ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
| ACPP-1751 | Human HAGH Protein (AC1751) | 2 µg | inquiry |
| ACPP-1723 | Human FGF 1 Protein, Sf9 (AC1723) | 2 µg | inquiry |
| ACPP-1703 | Human PITPNA Protein (AC1703) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.